End-Stage Renal Disease (ESRD) is characterized by a drop in kidney function below 10% of normal. Treatment involves kidney transplant or dialysis.
Currently, dialysis is performed at a dialysis center by means of an artificial kidney (hemodialyzer) in four-hour sessions, three times per week. In some cases, dialysis can be performed at home on a daily basis using the patient’s peritoneal membrane (of the abdomen) to act as a blood filter.
At-home peritoneal dialysis (PD) offers numerous benefits. For patients, it eliminates the need to travel to dialysis centers and provides flexibility to maintain everyday work and activities. For the health care system, PD presents a more affordable treatment modality.
Unfortunately, current PD systems are bulky and suffer from a particularly cumbersome setup and complicated regimen. They may also increase the risk of peritonitis.
The market seeks an effective, easy-to-use dialysis solution for improved treatment benefits and reduced health care costs.